Oesophagus

Leptin and the risk of Barrett’s oesophagus

B J Kendall¹, G A Macdonald², N K Hayward³, J B Prins², I Brown⁴, N Walker⁵, N Pandeya¹, A C Green¹, P M Webb¹, D C Whiteman¹ for the Study of Digestive Health

¹ Division of Population Studies and Human Genetics, Queensland Institute of Medical Research, Brisbane, Australia
² Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Brisbane, Australia
³ Division of Cancer and Cell Biology, Queensland Institute of Medical Research, Brisbane, Australia
⁴ Sullivan and Nicolaides Pathology, Brisbane, Australia
⁵ Queensland Medical Laboratories, Brisbane, Australia

Dr D C Whiteman, c/- Cancer and Population Studies Group, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, QLD 4029, Australia; david.whiteman{at}qimr.edu.au

Background: Obesity is associated with increased risks of Barrett’s oesophagus and oesophageal adenocarcinoma. Alterations in serum leptin and adiponectin, obesity-related cytokines, have been linked with several cancers and have been postulated as potential mediators of obesity-related carcinogenesis; however, the relationship with Barrett’s oesophagus remains unexplored.

Methods: Serum leptin and adiponectin concentrations were measured on two subsets of participants within a case–control study conducted in Brisbane, Australia. Cases were people aged 18–79 years with histologically confirmed Barrett’s oesophagus newly diagnosed between 2003 and 2006. Population controls, frequency matched by age and sex to cases, were randomly selected from the electoral roll. Phenotype and medical history data were collected through structured, self-completed questionnaires. Odds ratios (OR) and 95% CI were calculated using multivariable logistic regression analysis.

Results: In the pilot analysis (51 cases, 67 controls) risks of Barrett’s oesophagus were highest among those in the highest quartile of serum leptin (OR 4.6, 95% CI 0.6 to 33.4). No association was seen with adiponectin. In the leptin validation study (306 cases, 309 controls), there was a significant threefold increased risk of Barrett’s oesophagus among men in the highest quartile of serum leptin (OR 3.3, 95% CI 1.7 to 6.6) and this persisted after further adjustment for symptoms of gastro-oesophageal reflux (OR 2.4, 95% CI 1.1 to 5.2). In contrast, the risk of Barrett’s oesophagus among women decreased with increasing serum leptin concentrations.

Conclusions: High serum leptin is associated with an increased risk of Barrett’s oesophagus among men but not women. This association is not explained simply by higher body mass or gastro-oesophageal reflux among cases. The mechanism remains to be determined.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Robin Spiller and Magnus Simren
Gut 2008 57: 1-2. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Rubenstein, J H, Kao, J Y, Madanick, R D, Zhang, M, Wang, M, Spacek, M B, Donovan, J L, Bright, S D, Shaheen, N J (2009). Association of adiponectin multimers with Barrett's oesophagus. Gut 58: 1583-1589 [Abstract] [Full Text]  
• Jacobson, B C, Chan, A T, Giovannucci, E L, Fuchs, C S (2009). Body mass index and Barrett's oesophagus in women. Gut 58: 1460-1466 [Abstract] [Full Text]  
• Corley, D A, Kubo, A, Levin, T R, Block, G, Habel, L, Rumore, G, Quesenberry, C, Buffler, P (2009). Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut 58: 182-188 [Abstract] [Full Text]